CIK 0001124524
- Accelerated filer
Cryoport, Inc.
Sign in to watch- Ticker
- CYRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 880313393
- Phone
- +1 949-232-1900
- Business address
- 112 WESTWOOD PLACE, SUITE 350, BRENTWOOD, TN, 37027
- Former names
- CRYOPORT SYSTEMS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,702,237
- in 2 filings, $1.5M under 10b5-1 plans
Net −$1,702,237. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-15 | BADDOUR LINDA Director | Grant or award · Option to purchase common stock | +683 | 683 | ||
| 2021-03-15 | BADDOUR LINDA Director | Grant or award · Restricted Stock Rights | +341 | 341 | ||
| 2021-03-15 | BADDOUR LINDA Director | Grant or award · Restricted Stock Rights | +3,333 | 3,333 | ||
| 2021-03-11 | ZECCHINI EDWARD J Director | Option exercise | +4,167 | $5.04 | $21K | 39,190 |
| 2021-03-11 | ZECCHINI EDWARD J Director | Sale | −4,167 | $55.65 | $232K | 35,023 |
| 2021-03-11 | ZECCHINI EDWARD J Director | Option exercise · Option to purchase common stock | −4,167 | 0 | ||
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Option exercise | +11,342 | $3.07 | $35K | 30,342 |
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Option exercise | +7,231 | $1.87 | $14K | 37,573 |
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Option exercise | +11,831 | $3.21 | $38K | 49,404 |
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Sale | −3,974 | $54.65 | $217K | 45,430 |
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Sale | −9,357 | $55.33 | $518K | 36,073 |
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Option exercise · Options to purchase common stock | −11,342 | 0 | ||
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Option exercise · Options to purchase common stock | −11,831 | 0 | ||
| 2021-03-10 | Sawicki Mark W Chief Scientific Officer | Option exercise · Options to purchase common stock | −7,231 | 0 | ||
| 2021-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Grant or award · Option to purchase common stock | +21,333 | 21,333 | ||
| 2021-03-09 | STEFANOVICH ROBERT Chief Financial Officer | Grant or award · Restricted Stock Rights | +10,667 | 10,667 | ||
| 2021-03-09 | Sawicki Mark W Chief Scientific Officer | Grant or award · Option to purchase common stock | +21,333 | 21,333 | ||
| 2021-03-09 | Sawicki Mark W Chief Scientific Officer | Grant or award · Restricted Stock Rights | +10,667 | 10,667 | ||
| 2021-03-09 | SHELTON JERRELL Chief Executive Officer | Grant or award · Option to purchase common stock | +66,000 | 66,000 | ||
| 2021-03-09 | SHELTON JERRELL Chief Executive Officer | Grant or award · Restricted Stock Rights | +33,000 | 33,000 |
Page 23 of 28 · 541 trades